Literature DB >> 9512511

Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway.

T Miyazaki1, A Takaoka, L Nogueira, I Dikic, H Fujii, S Tsujino, Y Mitani, M Maeda, J Schlessinger, T Taniguchi.   

Abstract

Many cytokines transmit signals to the cell interior through activation of receptor-associated, Janus family protein tyrosine kinases (Jak PTKs). The interleukin-2 receptor (IL-2R) is associated with the Jak1 and Jak3 PTKs, and ligand-induced activation of these PTKs is essential for lymphocyte proliferation. Here, the nonreceptor PTK, Pyk2, was found to be activated following IL-2 stimulation in a Jak-dependent manner. Furthermore, physical association was detected between endogenous Pyk2 and Jak3, and a dominant interfering mutant of Pyk2 inhibited IL-2-induced cell proliferation without affecting Stat5 activation. Collectively, these results suggest that Pyk2 is a newly identified component of the Jak-mediated IL-2 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512511      PMCID: PMC316631          DOI: 10.1101/gad.12.6.770

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  36 in total

1.  STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction.

Authors:  T Takeshita; T Arita; M Higuchi; H Asao; K Endo; H Kuroda; N Tanaka; K Murata; N Ishii; K Sugamura
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

2.  Structure and function of a new STAT-induced STAT inhibitor.

Authors:  T Naka; M Narazaki; M Hirata; T Matsumoto; S Minamoto; A Aono; N Nishimoto; T Kajita; T Taga; K Yoshizaki; S Akira; T Kishimoto
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

3.  A new protein containing an SH2 domain that inhibits JAK kinases.

Authors:  T A Endo; M Masuhara; M Yokouchi; R Suzuki; H Sakamoto; K Mitsui; A Matsumoto; S Tanimura; M Ohtsubo; H Misawa; T Miyazaki; N Leonor; T Taniguchi; T Fujita; Y Kanakura; S Komiya; A Yoshimura
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

Review 4.  Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases.

Authors:  T Miyazaki; T Taniguchi
Journal:  Cancer Surv       Date:  1996

5.  A family of cytokine-inducible inhibitors of signalling.

Authors:  R Starr; T A Willson; E M Viney; L J Murray; J R Rayner; B J Jenkins; T J Gonda; W S Alexander; D Metcalf; N A Nicola; D J Hilton
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

6.  A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.

Authors:  M Hatakeyama; H Mori; T Doi; T Taniguchi
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

7.  A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation.

Authors:  I Dikic; G Tokiwa; S Lev; S A Courtneidge; J Schlessinger
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

8.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Authors:  T Takeshita; Y Goto; K Tada; K Nagata; H Asao; K Sugamura
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  The integrity of the conserved 'WS motif' common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction.

Authors:  T Miyazaki; M Maruyama; G Yamada; M Hatakeyama; T Taniguchi
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

10.  Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.

Authors:  N Arima; M Kamio; K Imada; T Hori; T Hattori; M Tsudo; M Okuma; T Uchiyama
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  16 in total

1.  Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.

Authors:  A Takaoka; N Tanaka; Y Mitani; T Miyazaki; H Fujii; M Sato; P Kovarik; T Decker; J Schlessinger; T Taniguchi
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration.

Authors:  M Okigaki; C Davis; M Falasca; S Harroch; D P Felsenfeld; M P Sheetz; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 3.  Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function.

Authors:  Hanne L Ostergaard; Tara L Lysechko
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Transcriptome-wide RNA interaction profiling reveals physical and functional targets of hnRNP L in human T cells.

Authors:  Ganesh Shankarling; Brian S Cole; Michael J Mallory; Kristen W Lynch
Journal:  Mol Cell Biol       Date:  2013-10-28       Impact factor: 4.272

5.  Cell type-specific roles of Jak3 in IL-2-induced proliferative signal transduction.

Authors:  Hodaka Fujii
Journal:  Biochem Biophys Res Commun       Date:  2007-01-22       Impact factor: 3.575

6.  Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.

Authors:  M B Meads; B Fang; L Mathews; J Gemmer; L Nong; I Rosado-Lopez; T Nguyen; J E Ring; W Matsui; A R MacLeod; J A Pachter; L A Hazlehurst; J M Koomen; K H Shain
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

Review 7.  Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement.

Authors:  Nicole M Chapman; Jon C D Houtman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway.

Authors:  Appakkudal R Anand; Ritu Bradley; Ramesh K Ganju
Journal:  Mol Immunol       Date:  2008-10-26       Impact factor: 4.407

Review 9.  Cross-regulation of signaling by ITAM-associated receptors.

Authors:  Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

10.  Inhibition of nitric oxide synthase and farnesyltransferase change the activities of several transcription factors.

Authors:  E Zhuravliova; T Barbakadze; N Narmania; J Ramsden; D Mikeladze
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.